Status | Study |
Not yet recruiting |
Study Name: Prostatic Hyperplasia Treatment and Cancer Prevention Condition: Prostatic Hyperplasia Date: 2016-12-12 Interventions: Other: Placebo observation of |
Recruiting |
Study Name: Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams Condition: Prostatic Hyperplasia Date: 2015-03-12 Interventions: Device: Embosphere Microspheres |
Active, not recruiting |
Study Name: Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia Condition: Benign Prostatic Hyperplasia Date: 2014-07-29 Interventions: Drug: Embozene Microspheres Intraarterial application |
Completed |
Study Name: Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia Condition: Prostatic Hyperplasia Date: 2014-01-23 Interventions: Drug: Dutasteride 0.5mg capsules |
Recruiting |
Study Name: Prostate Embolization for Benign Prostatic Hyperplasia Condition: Benign Prostatic Hyperplasia Date: 2013-08-14 Interventions: Procedure: Prostatic Embolization |
Completed |
Study Name: Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia Condition: Benign Prostatic Hyperplasia Date: 2012-12-21 Interventions: Drug: Silodosin 8 mg daily for 24 weeks |
Terminated |
Study Name: Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia Condition: Prostatic Hyperplasia Date: 2012-06-28 Interventions: Drug: Dutasteride/Tamsulosin 0.5 mg dutasteride/ 0.4 mg tamsulosin once daily for the duration of 180 da |
Completed |
Study Name: Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH) Condition: Benign Prostatic Hyperplasia Date: 2011-10-24 Interventions: Drug: Tadalafil 5 mg (2 x 2.5- |
Terminated |
Study Name: An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL Condition: Benign Prostatic Hyperplasia Date: 2011-05-10 |
Completed |
Study Name: Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic Hyperplasia Condition: Prostatic Hyperplasia Date: 2011-04-07 Interventions: Drug: Adherent with 5-alpha-reductase inhibitor (5ARI) therapy |